Cargando…
Melanoma Cell Death Mechanisms
Over recent years, several new molecular and immunogenic therapeutic approaches to melanoma treatment have been approved and implemented in clinical practice. Mechanisms of resistance to these new therapies have become a major problem. Mutation-specific pharmacotherapy can result in simultaneous eme...
Autores principales: | Broussard, Lindsey, Howland, Amanda, Ryu, Sunhyo, Song, Kyungsup, Norris, David, Armstrong, Cheryl A., Song, Peter I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chonnam National University Medical School
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165917/ https://www.ncbi.nlm.nih.gov/pubmed/30288368 http://dx.doi.org/10.4068/cmj.2018.54.3.135 |
Ejemplares similares
-
Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma
por: Ryu, Sunhyo, et al.
Publicado: (2017) -
Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes
por: Ryu, Sunhyo, et al.
Publicado: (2019) -
Scavenger Receptor Class A to E Involved in Various Cancers
por: Ryu, Sunhyo, et al.
Publicado: (2020) -
The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018) -
The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human Keratinocytes
por: Ryu, Sunhyo, et al.
Publicado: (2015)